# EDGAR Filing Document

**Accession Number:** 0001540013
**File Stem:** 0001104659-23-032802
**Filing Date:** 2023-3
**Character Count:** 5050
**Document Hash:** 8943c8886c014f100c7449a64904a8de
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-032802.hdr.sgml**: 20230315

**ACCESSION NUMBER**: 0001104659-23-032802

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230315

**FILED AS OF DATE**: 20230315

**DATE AS OF CHANGE**: 20230315

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Quipt Home Medical Corp.
- **CENTRAL INDEX KEY:** 0001540013
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40413
- **FILM NUMBER:** 23735576

**BUSINESS ADDRESS:**
- **STREET 1:** 1019 TOWN DRIVE
- **CITY:** WILDER
- **STATE:** KY
- **ZIP:** 41076
- **BUSINESS PHONE:** 859-878-2220

**MAIL ADDRESS:**
- **STREET 1:** 1019 TOWN DRIVE
- **CITY:** WILDER
- **STATE:** KY
- **ZIP:** 41076

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Protech Home Medical Corp.
- **DATE OF NAME CHANGE:** 20200714

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Patient Home Monitoring Corp.
- **DATE OF NAME CHANGE:** 20120119

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934**

**For the month of March 2023**

**Commission File Number: 001-40413**

**Quipt Home Medical Corp.**

**(Translation of registrant's name into English)**

**1019 Town Drive**

**Wilder, Kentucky 41076**

**(Address of principal executive office)**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ◻ Form 40-F ⌧

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ◻

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ◻

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| [99.1](tm239691d1_ex99-1.htm) | [Press Release dated March 15, 2023](tm239691d1_ex99-1.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **Quipt Home Medical Corp.** |
| Date: March 15, 2023 | /s/ *Gregory Crawford* |
|  | Chief Executive Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

**QUIPT HOME MEDICAL TO PARTICIPATE AT THE SIDOTI SMALL-CAP VIRTUAL INVESTOR CONFERENCE ON MARCH 22-23, 2023**

**WEBCASTED PRESENTATION TO BE HELD WEDNESDAY, MARCH 22, 2023**

Cincinnati, Ohio – March 15, 2023 – Quipt Home Medical Corp. (the "**Company**" or "**Quipt**") (NASDAQ: QIPT), (TSXV: QIPT) a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that members of its management team will host a webcasted presentation and participate in 1x1 meetings with institutional investors at the upcoming Sidoti March Small-Cap Virtual Conference on March 22-23, 2023.

**<u>Webcasted Presentation</u>**

---

| | |
|:---|:---|
| **Event:** | Sidoti Virtual Investor Conference |
| **Date:** | Wednesday, March 22, 2023 |
| **Time:** | 1:45pm ET |

---

The live webcast of the presentation will be available by visiting the investors' section of the company's website at <u>www.Quipthomemedical.com</u>. The webcast will also be available for replay on the company's website following the event.

**ABOUT QUIPT HOME MEDICAL**

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient.

*Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of ‎the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.‎*

For further information please visit our website at www.Quipthomemedical.com, or contact:

Cole Stevens

VP of Corporate Development

Quipt Home Medical Corp.

859-300-6455

<u>cole.stevens@myquipt.com</u>

Gregory Crawford<br> Chief Executive Officer<br> Quipt Home Medical Corp.<br> 859-300-6455<br> <u>investorinfo@myquipt.com</u>